Stay updated on Upadacitinib vs Methotrexate in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in RA Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference0.5%
- Check20 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check34 days agoChange DetectedThe page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference0.7%
- Check41 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check56 days agoChange DetectedThe page has removed a citation regarding an erratum for a study on the safety profile of upadacitinib in rheumatoid arthritis.SummaryDifference0.2%
Stay in the know with updates to Upadacitinib vs Methotrexate in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.